EDG3 is necessary for the stimulation of the serine threonine kinase, Akt3, by the vascular endothelial growth factor (VEGF), and reduced levels of Akt kinase leads to increased apoptosis of cancer cells [47]. The gene discussed is MARK2; the disease is cancer.